Archive · 19 Jan 2026
Hyaluronic Acid Gel Shows Promise in Gynaecological Cancer Treatment
Scientists in Australia did a study to see if a special gel made from hyaluronic acid could help women with gynaecological cancer.
The gel is already used in men for prostate cancer treatment.
The researchers found that the gel can safely create space between the tumour and the rectum during radiation treatment.
This space helps protect the rectum from too much radiation and allows more radiation to target the tumour.
The gel is easy to use, doesn't cause discomfort, and stays in place during treatment.
It also dissolves safely in the body over time.
This could make cancer treatment safer and more effective for women.
Australian researchers demonstrated the safety and feasibility of using stabilised hyaluronic acid (sHA) gel in gynaecological cancer treatment.
The gel is already approved for use in prostate cancer radiation treatment in Australia.
The study involved 12 patients and showed the gel effectively creates space between the tumour and the rectum during MRI-guided brachytherapy.
The gel was easy to use, visible on MRI scans, and caused no discomfort or complications for patients.
The gel has the potential to reduce radiation exposure to healthy tissue and improve treatment outcomes for gynaecological cancers.
- Who
- Researchers from Monash University in Australia
- What
- A study on the use of stabilised hyaluronic acid (sHA) gel in gynaecological cancer treatment
- When
- Published on January 19
- Where
- Australia
- Why
- To reduce radiation exposure to the rectum and improve treatment effectiveness
- Study Location
- Australia
- Lead Institution
- Monash University
- Number of Patients
- 12
- Journal
- Journal of Medical Radiation Sciences
- Approval Status
- Approved for prostate cancer in Australia